CN Patent

CN121816178A — 用于治疗患有与阻塞性睡眠呼吸暂停和白天过度嗜睡相关的认知受损的受试者的认知受损的索安非托

Assigned to Aksam Treatment Co ltd · Expires 2026-04-07 · 0y expired

What this patent protects

本发明涉及氨基甲酰基苯丙氨醇化合物和使用其增强患有与阻塞性睡眠呼吸暂停和白天过度嗜睡相关的认知受损的受试者的一种或多种认知功能的方法以及治疗这类患者的一种或多种认知受损的方法。

USPTO Abstract

本发明涉及氨基甲酰基苯丙氨醇化合物和使用其增强患有与阻塞性睡眠呼吸暂停和白天过度嗜睡相关的认知受损的受试者的一种或多种认知功能的方法以及治疗这类患者的一种或多种认知受损的方法。

Drugs covered by this patent

Patent Metadata

Patent number: CN121816178A
Jurisdiction: CN
Classification: —
Expires: 2026-04-07
Drug substance claim: No
Drug product claim: No
Assignee: Aksam Treatment Co ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.